Eden Research (LON:EDEN) Trading Down 4.7% – Time to Sell?

Shares of Eden Research plc (LON:EDEN) traded down 4.7% during trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.43 ($0.04). 291,737 shares were traded during mid-day trading, a decline of 69% from the average session volume of 928,598 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The business’s 50 day moving average price is GBX 3.87 and its 200 day moving average price is GBX 3.95. The stock has a market capitalization of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insider Transactions at Eden Research

In other Eden Research news, insider Lykele van der Broek bought 256,000 shares of the business’s stock in a transaction that occurred on Thursday, February 6th. The stock was bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Company insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.